サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1363005

ヒアルロニダーゼの市場規模、シェア、動向分析レポート：タイプ別、用途別、地域別、セグメント予測、2023年～2030年

Hyaluronidase Market Size, Share & Trends Analysis Report By Type (Animal Derived, Synthetic), By Application (Dermatology, Chemotherapy), By Region, And Segment Forecasts, 2023 - 2030
出版日: | 発行: Grand View Research | ページ情報: 英文 130 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.58円
ヒアルロニダーゼの市場規模、シェア、動向分析レポート：タイプ別、用途別、地域別、セグメント予測、2023年～2030年
出版日: 2023年09月13日
発行: Grand View Research
ページ情報: 英文 130 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

ヒアルロニダーゼ市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界のヒアルロニダーゼ市場規模は、2023年から2030年にかけてCAGR 8.4%で成長し、2030年には17億3,460万米ドルに達すると予測されています。

低侵襲性美容処置の重要性は、長年にわたって大幅に増加しており、特に先進国において、世界中の美容処置の採用パターンを評価するために様々な人口統計学的調査研究が実施されています。

ヒアルロン酸フィラーは、世界中で実施されている低侵襲美容施術の最も重要な構成要素を形成しています。ヒアルロニダーゼはこれらの処置を行う場合に主に好まれるため、低侵襲美容手術の増加は市場成長にプラスの影響を与えると予想されます。皮膚フィラーは、低侵襲的な顔の美容手術において重要な用途を有しており、そのため合併症の報告数も増加しています。

臨床医は、ヒアルロン酸注入の合併症を効果的に治療するために、合併症に関連する症状を完全に認識する必要があります。目的の薬剤が手術や治療の部位で容易に入手できるような、緊急時に適した効果的な行動プロトコルを確立することが極めて重要です。これはヒアルロン酸フィラー注入の悪影響をコントロールするのに役立ちます。

ヒアルロニダーゼ市場レポートハイライト

  • 動物由来ヒアルロニダーゼセグメントは2022年に67.0%の最大の収益シェアを占め、予測期間を通じてこの傾向を維持すると予測されます。
  • 合成ヒアルロニダーゼセグメントは予測期間中最も速いCAGR 9.4%を記録すると予測されます。
  • 皮膚科セグメントは、2022年に約44.6%の最大の売上シェアを占めました。
  • 化学療法分野は予測期間中に最速のCAGR 10.5%を記録すると予測されています。
  • 北米は、新規美容治療の高い普及率により、2022年に38.0%の最大の収益シェアを獲得し、市場を独占しました。加えて、この地域の皮膚科医は、新しい非外科的美容施術やヒアルロニダーゼベースの注入剤を開発しており、これは注入可能な皮膚充填剤の中でも高く推奨されています。
  • アジア太平洋は、ヒアルロニダーゼベースの治療における多くの未開拓の成長機会により、最も速い成長を示すと予測されます。
  • 現地メーカーの強固なネットワークがこの地域の収益に大きく貢献しています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 ヒアルロニダーゼ市場変数、動向および範囲

  • 市場系統の見通し
    • 親市場の見通し
    • 関連/付随市場の見通し
  • 普及と成長の見通しマッピング
  • 市場力学
    • 市場促進要因の分析
    • 市場抑制要因分析
  • ヒアルロニダーゼ市場分析ツール
    • 業界分析- ポーターのファイブフォース分析
    • PESTEL分析

第4章 ヒアルロニダーゼ：タイプの推定・動向分析

  • ヒアルロニダーゼ市場：重要なポイント
  • ヒアルロニダーゼ市場：動向と市場シェア分析、2022年および2030年
  • 動物由来ヒアルロニダーゼ
  • 合成ヒアルロニダーゼ

第5章 ヒアルロニダーゼ：用途の推定・動向分析

  • ヒアルロニダーゼ市場：重要なポイント
  • ヒアルロニダーゼ市場：動向と市場シェア分析、2022年および2030年
  • 皮膚科
  • 化学療法
  • 眼科
  • 形成外科
  • その他

第6章 ヒアルロニダーゼ市場：地域の推定・動向分析

  • 地域別の展望
  • 地域別のヒアルロニダーゼ市場：重要なポイント
  • 北米
    • 市場推計・予測、2018～2030年
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • スウェーデン
    • ノルウェー
    • デンマーク
  • アジア太平洋地域
    • 日本
    • 中国
    • インド
    • オーストラリア
    • タイ
    • 韓国
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • アルゼンチン
  • 中東・アフリカ
    • サウジアラビア
    • 南アフリカ
    • アラブ首長国連邦
    • クウェート

第7章 競合情勢

  • 主要市場参入企業による最近の動向と影響分析
  • 市場参入企業の分類
    • Amphastar Pharmaceuticals, Inc.
    • PrimaPharma, Inc.
    • Halozyme, Inc.
    • Bausch & Lomb Incorporated
    • The Cooper Companies Inc.
    • Sun Pharmaceutical Industries Ltd.
    • STEMCELL Technologies Inc.
    • Shreya Life Sciences Pvt. Ltd.
図表

List of Tables

  • Table 1 List of Abbreviations
  • Table 2 North America hyaluronidase market, by type, 2018 - 2030 (USD Million)
  • Table 3 North America hyaluronidase market, by application, 2018 - 2030 (USD Million)
  • Table 4 North America hyaluronidase market, by region, 2018 - 2030 (USD Million)
  • Table 5 U.S. hyaluronidase market, by type, 2018 - 2030 (USD Million)
  • Table 6 U.S. hyaluronidase market, by application, 2018 - 2030 (USD Million)
  • Table 7 Canada hyaluronidase market, by type, 2018 - 2030 (USD Million)
  • Table 8 Canada hyaluronidase market, by application, 2018 - 2030 (USD Million)
  • Table 9 Europe hyaluronidase market, by type, 2018 - 2030 (USD Million)
  • Table 10 Europe hyaluronidase market, by application, 2018 - 2030 (USD Million)
  • Table 11 Europe hyaluronidase market, by region, 2018 - 2030 (USD Million)
  • Table 12 Germany hyaluronidase market, by type, 2018 - 2030 (USD Million)
  • Table 13 Germany hyaluronidase market, by application, 2018 - 2030 (USD Million)
  • Table 14 UK hyaluronidase market, by type, 2018 - 2030 (USD Million)
  • Table 15 UK hyaluronidase market, by application, 2018 - 2030 (USD Million)
  • Table 16 France hyaluronidase market, by type, 2018 - 2030 (USD Million)
  • Table 17 France hyaluronidase market, by application, 2018 - 2030 (USD Million)
  • Table 18 Italy hyaluronidase market, by type, 2018 - 2030 (USD Million)
  • Table 19 Italy hyaluronidase market, by application, 2018 - 2030 (USD Million)
  • Table 20 Spain hyaluronidase market, by type, 2018 - 2030 (USD Million)
  • Table 21 Spain hyaluronidase market, by application, 2018 - 2030 (USD Million)
  • Table 22 Sweden hyaluronidase market, by type, 2018 - 2030 (USD Million)
  • Table 23 Sweden hyaluronidase market, by application, 2018 - 2030 (USD Million)
  • Table 24 Norway hyaluronidase market, by type, 2018 - 2030 (USD Million)
  • Table 25 Norway hyaluronidase market, by application, 2018 - 2030 (USD Million)
  • Table 26 Denmark hyaluronidase market, by type, 2018 - 2030 (USD Million)
  • Table 27 Denmark hyaluronidase market, by application, 2018 - 2030 (USD Million)
  • Table 28 Asia Pacific hyaluronidase market, by type, 2018 - 2030 (USD Million)
  • Table 29 Asia Pacific hyaluronidase market, by application, 2018 - 2030 (USD Million)
  • Table 30 Asia Pacific hyaluronidase market, by region, 2018 - 2030 (USD Million)
  • Table 31 China hyaluronidase market, by type, 2018 - 2030 (USD Million)
  • Table 32 China hyaluronidase market, by application, 2018 - 2030 (USD Million)
  • Table 33 Japan hyaluronidase market, by type, 2018 - 2030 (USD Million)
  • Table 34 Japan hyaluronidase market, by application, 2018 - 2030 (USD Million)
  • Table 35 India hyaluronidase market, by type, 2018 - 2030 (USD Million)
  • Table 36 India hyaluronidase market, by application, 2018 - 2030 (USD Million)
  • Table 37 Australia hyaluronidase market, by type, 2018 - 2030 (USD Million)
  • Table 38 Australia hyaluronidase market, by application, 2018 - 2030 (USD Million)
  • Table 39 Thailand hyaluronidase market, by type, 2018 - 2030 (USD Million)
  • Table 40 Thailand hyaluronidase market, by application, 2018 - 2030 (USD Million)
  • Table 41 South Korea hyaluronidase market, by type, 2018 - 2030 (USD Million)
  • Table 42 South Korea hyaluronidase market, by application, 2018 - 2030 (USD Million)
  • Table 43 Latin America hyaluronidase market, by type, 2018 - 2030 (USD Million)
  • Table 44 Latin America hyaluronidase market, by application, 2018 - 2030 (USD Million)
  • Table 45 Latin America hyaluronidase market, by region, 2018 - 2030 (USD Million)
  • Table 46 Brazil hyaluronidase market, by type, 2018 - 2030 (USD Million)
  • Table 47 Brazil hyaluronidase market, by application, 2018 - 2030 (USD Million)
  • Table 48 Mexico hyaluronidase market, by type, 2018 - 2030 (USD Million)
  • Table 49 Mexico hyaluronidase market, by application, 2018 - 2030 (USD Million)
  • Table 50 Argentina hyaluronidase market, by type, 2018 - 2030 (USD Million)
  • Table 51 Argentina hyaluronidase market, by application, 2018 - 2030 (USD Million)
  • Table 52 Middle East and Africa hyaluronidase market, by type, 2018 - 2030 (USD Million)
  • Table 53 Middle East and Africa hyaluronidase market, by application, 2018 - 2030 (USD Million)
  • Table 54 Middle East and Africa hyaluronidase market, by region, 2018 - 2030 (USD Million)
  • Table 55 South Africa hyaluronidase market, by type, 2018 - 2030 (USD Million)
  • Table 56 South Africa hyaluronidase market, by application, 2018 - 2030 (USD Million)
  • Table 57 Saudi Arabia hyaluronidase market, by type, 2018 - 2030 (USD Million)
  • Table 58 Saudi Arabia hyaluronidase market, by application, 2018 - 2030 (USD Million)
  • Table 59 UAE hyaluronidase market, by type, 2018 - 2030 (USD Million)
  • Table 60 UAE hyaluronidase market, by application, 2018 - 2030 (USD Million)
  • Table 61 Kuwait hyaluronidase market, by type, 2018 - 2030 (USD Million)
  • Table 62 Kuwait hyaluronidase market, by application, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Hyaluronidase: Market outlook
  • Fig. 9 Hyaluronidase: Competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 Hyaluronidase market driver impact
  • Fig. 15 Hyaluronidase market restraint impact
  • Fig. 16 Hyaluronidase market strategic initiatives analysis
  • Fig. 17 Hyaluronidase market: Type movement analysis
  • Fig. 18 Hyaluronidase market: type outlook and key takeaways
  • Fig. 19 Animal derived hyaluronidase market estimates and forecasts, 2018 - 2030
  • Fig. 20 Synthetic hyaluronidase market estimates and forecasts, 2018 - 2030
  • Fig. 21 Hyaluronidase market: Application movement analysis
  • Fig. 22 Hyaluronidase market: Application outlook and key takeaways
  • Fig. 23 Dermatology market estimates and forecasts, 2018 - 2030
  • Fig. 24 Chemotherapy market estimates and forecasts, 2018 - 2030
  • Fig. 25 Ophthalmology market estimates and forecasts, 2018 - 2030
  • Fig. 26 Plastic surgery market estimates and forecasts, 2018 - 2030
  • Fig. 27 Others market estimates and forecasts, 2018 - 2030
  • Fig. 28 Global Hyaluronidase market: Regional movement analysis
  • Fig. 29 Global Hyaluronidase market: Regional outlook and key takeaways
  • Fig. 30 North America market estimates and forecasts, 2018 - 2030
  • Fig. 31 U.S. market estimates and forecasts, 2018 - 2030
  • Fig. 32 Canada market estimates and forecasts, 2018 - 2030
  • Fig. 33 Europe. market estimates and forecasts, 2018 - 2030
  • Fig. 34 UK market estimates and forecasts, 2018 - 2030
  • Fig. 35 Germany market estimates and forecasts, 2018 - 2030
  • Fig. 36 France market estimates and forecasts, 2018 - 2030
  • Fig. 37 Italy market estimates and forecasts, 2018 - 2030
  • Fig. 38 Spain market estimates and forecasts, 2018 - 2030
  • Fig. 39 Sweden market estimates and forecasts, 2018 - 2030
  • Fig. 40 Norway market estimates and forecasts, 2018 - 2030
  • Fig. 41 Denmark market estimates and forecasts, 2018 - 2030
  • Fig. 42 Asia Pacific market estimates and forecasts, 2018 - 2030
  • Fig. 43 Japan market estimates and forecasts, 2018 - 2030
  • Fig. 44 China market estimates and forecasts, 2018 - 2030
  • Fig. 45 India market estimates and forecasts, 2018 - 2030
  • Fig. 46 Australia market estimates and forecasts, 2018 - 2030
  • Fig. 47 Thailand market estimates and forecasts, 2018 - 2030
  • Fig. 48 South Korea market estimates and forecasts, 2018 - 2030
  • Fig. 49 Latin America market estimates and forecasts, 2018 - 2030
  • Fig. 50 Brazil market estimates and forecasts, 2018 - 2030
  • Fig. 51 Mexico market estimates and forecasts, 2018 - 2030
  • Fig. 52 Argentina market estimates and forecasts, 2018 - 2030
  • Fig. 53 Middle East and Africa. market estimates and forecasts, 2018 - 2030
  • Fig. 54 Saudi Arabia market estimates and forecasts, 2018 - 2030
  • Fig. 55 South Africa market estimates and forecasts, 2018 - 2030
  • Fig. 56 UAE market estimates and forecasts, 2018 - 2030
  • Fig. 57 Kuwait market estimates and forecasts, 2018 - 2030
目次
Product Code: GVR-4-68038-132-0

Hyaluronidase Market Growth & Trends:

The global hyaluronidase market size is expected to reach USD 1,734.6 million by 2030 growing at a CAGR of 8.4% from 2023 to 2030, according to a new report by Grand View Research, Inc.. The significance of minimally invasive cosmetic procedures has increased considerably over the years and various demographic research studies have been conducted to evaluate the adoption pattern of cosmetic treatments across the globe, especially in developed countries.

Hyaluronic acid fillers form the most important component of minimally invasive aesthetic procedures carried out across the globe. Since hyaluronidase is mostly preferred while conducting these procedures, a growing number of minimally invasive aesthetic surgeries are expected to positively impact market growth. Dermal fillers have significant applications in minimally invasive facial aesthetic procedures, which has also led to an increase in the number of reported complications.

Clinicians are required to be entirely aware of the symptoms associated with hyaluronic acid injection complications in order to treat them effectively. It is crucial to establish effective protocols of action suitable for emergencies wherein the desired agents are readily available at the site of surgery or treatment. This aids in controlling the adverse impact of hyaluronic acid filler injections.

Hyaluronidase Market Report Highlights:

  • Animal derived hyaluronidase segment held the largest revenue share of 67.0% in 2022 and are anticipated to maintain this trend throughout the forecast period
  • Synthetic hyaluronidase segment is anticipated to register the fastest CAGR of 9.4% over the forecast period
  • The Dermatology segment held the largest revenue share of approximately 44.6% in 2022
  • The chemotherapy segment is estimated to register the fastest CAGR of 10.5% over the forecast period.
  • North America dominated the market in 2022 with the largest revenue share of 38.0% due to the high penetration of novel cosmetic treatments. In addition, dermatologists in this region are developing new non-surgical cosmetic procedures and hyaluronidase-based injectables which are among the highly recommended injectable dermal fillers
  • Asia Pacific is projected to witness the fastest growth owing to the numerous untapped growth opportunities in hyaluronidase-based treatments
  • A robust network of local manufacturers has significantly contributed to the revenue generated from this region

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Type
    • 1.1.2. Application
    • 1.1.3. Regional scope
    • 1.1.4. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Type outlook
    • 2.2.2. Application outlook
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Hyaluronidase Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market Driver Analysis
    • 3.3.2. Market Restraint Analysis
  • 3.4. Hyaluronidase Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic Landscape

Chapter 4. Hyaluronidase: Type Estimates & Trend Analysis

  • 4.1. Hyaluronidase Market: Key Takeaways
  • 4.2. Hyaluronidase Market: Movement & Market Share Analysis, 2022 & 2030
  • 4.3. Animal-derived hyaluronidase
    • 4.3.1. Animal-derived hyaluronidase market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4. Synthetic hyaluronidase
    • 4.4.1. Synthetic hyaluronidase market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Hyaluronidase: Application Estimates & Trend Analysis

  • 5.1. Hyaluronidase Market: Key Takeaways
  • 5.2. Hyaluronidase Market: Movement & Market Share Analysis, 2022 & 2030
  • 5.3. Dermatology
    • 5.3.1. Dermatology market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.4. Chemotherapy
    • 5.4.1. Chemotherapy market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.5. Ophthalmology
    • 5.5.1. Ophthalmology market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.6. Plastic Surgery
    • 5.6.1. Plastic Surgery market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.7. Others
    • 5.7.1. Other market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Hyaluronidase Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Outlook
  • 6.2. Hyaluronidase Market by Region: Key Takeaways
  • 6.3. North America
    • 6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.3.2. U.S.
      • 6.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.3.3. Canada
      • 6.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.4. Europe
    • 6.4.1. UK
      • 6.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.2. Germany
      • 6.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.3. France
      • 6.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.4. Italy
      • 6.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.5. Spain
      • 6.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.6. Sweden
      • 6.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.7. Norway
      • 6.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.8. Denmark
      • 6.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.5. Asia Pacific
    • 6.5.1. Japan
      • 6.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.2. China
      • 6.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.3. India
      • 6.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.4. Australia
      • 6.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.5. Thailand
      • 6.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.6. South Korea
      • 6.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.6. Latin America
    • 6.6.1. Brazil
      • 6.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.6.2. Mexico
      • 6.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.6.3. Argentina
      • 6.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.7. MEA
    • 6.7.1. Saudi Arabia
      • 6.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.2. South Africa
      • 6.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.3. UAE
      • 6.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.4. Kuwait
      • 6.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Market Participant Categorization
    • 7.2.1. Amphastar Pharmaceuticals, Inc.
      • 7.2.1.1. Company overview
      • 7.2.1.2. Financial performance
      • 7.2.1.3. Product benchmarking
      • 7.2.1.4. Strategic initiatives
    • 7.2.2. PrimaPharma, Inc.
      • 7.2.2.1. Company overview
      • 7.2.2.2. Financial performance
      • 7.2.2.3. Product benchmarking
      • 7.2.2.4. Strategic initiatives
    • 7.2.3. Halozyme, Inc.
      • 7.2.3.1. Company overview
      • 7.2.3.2. Financial performance
      • 7.2.3.3. Product benchmarking
      • 7.2.3.4. Strategic initiatives
    • 7.2.4. Bausch & Lomb Incorporated
      • 7.2.4.1. Company overview
      • 7.2.4.2. Financial performance
      • 7.2.4.3. Product benchmarking
      • 7.2.4.4. Strategic initiatives
    • 7.2.5. The Cooper Companies Inc.
      • 7.2.5.1. Company overview
      • 7.2.5.2. Financial performance
      • 7.2.5.3. Product benchmarking
      • 7.2.5.4. Strategic initiatives
    • 7.2.6. Sun Pharmaceutical Industries Ltd.
      • 7.2.6.1. Company overview
      • 7.2.6.2. Financial performance
      • 7.2.6.3. Product benchmarking
      • 7.2.6.4. Strategic initiatives
    • 7.2.7. STEMCELL Technologies Inc.
      • 7.2.7.1. Company overview
      • 7.2.7.2. Financial performance
      • 7.2.7.3. Product benchmarking
      • 7.2.7.4. Strategic initiatives
    • 7.2.8. Shreya Life Sciences Pvt. Ltd.
      • 7.2.8.1. Company overview
      • 7.2.8.2. Financial performance
      • 7.2.8.3. Product benchmarking
      • 7.2.8.4. Strategic initiatives